Home › Lupus Nephritis › California › San Francisco
Lupus Nephritis clinical trials in San Francisco, CA
7 studies for Lupus Nephritis are looking for participants at sites in and around San Francisco (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
RecruitingPhase 2
- UCSF Benioff Childrens Hospital, San Francisco
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
RecruitingPhase 1
- University of California San Francisco - Zuckerberg San Francisco General, San Francisco
VIBRANT: VIB4920 for Active Lupus Nephritis
RecruitingPhase 2
- University of California San Francisco School of Medicine: Lupus Clinic and Rheumatology Clinical Research Center, San Francisco
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
RecruitingPhase 2
- University of California, San Francisco, San Francisco
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
RecruitingPhase 2
- University of California San Francisco, San Francisco
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
RecruitingPhase 1/2
- Research Site, San Francisco
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RecruitingPhase 1
- University of California San Francisco, San Francisco
Lupus Nephritis trials in other cities
- New York City, NY10 studies
- Atlanta, GA9 studies
- Chicago, IL9 studies
- Durham, NC9 studies
- Houston, TX8 studies
- Boston, MA7 studies
- Philadelphia, PA6 studies
- St. Louis, MO5 studies
- Miami, FL5 studies
- Dallas, TX4 studies
- Gainesville, FL4 studies
- Syracuse, NY4 studies
Other studies in San Francisco
- Prostate Cancer44 studies
- Breast Cancer40 studies
- Cancer (all types)38 studies
- Non-Small Cell Lung Cancer37 studies
- Heart Failure29 studies
- Metastatic Cancer25 studies
- Lung Cancer23 studies
- Melanoma21 studies
- Ovarian Cancer20 studies
- Cardiovascular Disease20 studies
- Pancreatic Cancer19 studies
- Glioblastoma19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.